Oncology

Latest News

Highlights From ACCC Fall 2024
ICYMI: Highlights From ACCC Fall 2024

January 1st 2025

Top content from the Association of Cancer Care Centers (ACCC) fall conference included topics on patient participation, new cancer care programs, prior authorization processing, and more.

Top 5 Most-Read Oncology Articles of 2024
Top 5 Most-Read Oncology Content of 2024

December 25th 2024

Most Popular Articles of 2024 in Evidence-Based Oncology
Most Popular Articles of 2024 in Evidence-Based Oncology

December 23rd 2024

Highlights From ASCO 2024
ICYMI: Highlights From ASCO 2024

December 21st 2024

chemotherapy | Image credit: Penn Medicine
The High Cost of Shortages of Low-Cost Chemotherapy

December 19th 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Site Logo
November 17th 2016

Addressing the Psychosocial Needs in Older Breast Cancer Patients

Surabhi Dangi-Garimella, PhD
A study conducted in Canada to estimate the prevalence of psychotropic and opioid medication use by older women diagnosed with breast cancer found a significant increase in use, especially during the active treatment phase.
Site Logo
November 16th 2016

First-in-Human Trial of CRISPR-Cas9 Begins in Lung Cancer Patients

Surabhi Dangi-Garimella, PhD
A hospital in China has made history by injecting a patient with lung cancer with revolutionary, yet controversial, CRISPR-Cas9—edited T cells. The first patient was injected on October 28.
Site Logo
November 15th 2016

BLA for Bevacizumab Biosimilar Filed Based on Phase 3 NSCLC Data

Surabhi Dangi-Garimella, PhD
Amgen and Allergan have announced that they have submitted a Biologics License Application (BLA) for ABP 215, a biosimilar to bevacizumab (Avastin).
Site Logo
November 15th 2016

Combining IORT With Chemotherapy Improves Survival in Pancreatic Cancer

Surabhi Dangi-Garimella, PhD
A new study conducted at the Massachusetts General Hospital evaluated the impact of intraoperative radiotherapy (IORT), along with induction chemotherapy and chemo-radiotherapy, in patients with advanced disease, and observed hints of success.
Site Logo
November 14th 2016

Prospective Trial Confirms Important Role of Vitamin D in Breast Cancer

Surabhi Dangi-Garimella, PhD
A prospective trial among breast cancer patients enrolled in The Pathways Study has found that higher levels of vitamin D can lower the risk of breast cancer morbidity and mortality.
Site Logo
November 12th 2016

Genetic Factors Can Help Tailor Surveillance Programs for Melanoma

Surabhi Dangi-Garimella, PhD
A study conducted in Australia has concluded that a person’s inherited risk factors for melanoma should be considered when developing self-examination and surveillance programs.
Site Logo
November 11th 2016

The Fate of Cancer Moonshot in 2017

Surabhi Dangi-Garimella, PhD
Will Vice President Joe Biden's Cancer Moonshot initiative be able to sustain it's momentum in 2017 following the transition in government?
Site Logo
November 10th 2016

Nivolumab Approved in Patients With Recurrent SCCHN

AJMC Staff
The FDA today granted approval to the programmed death ligand-1 inhibitor, nivolumab (Opdivo), for treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN), following platinum-based treatment.
Site Logo
November 10th 2016

Medical Home Transformation and Breast Cancer Screening

Amy W. Baughman, MD, MPH Phyllis Brawarsky, MPH Tracy Onega, PhD, MS Tor D. Tosteson, ScD Qianfei Wang, MS Anna N.A. Tosteson, ScD Jennifer S. Haas, MD, MSc
Breast cancer screening may not improve in early medical home implementation.
Site Logo
November 10th 2016

US Cigarette Smoking Rate Sees a 5% Decrease Since 2005

Surabhi Dangi-Garimella, PhD
According to CDC’s Morbidity and Mortality Weekly Report, the cigarette smoking rate of adults in the United States has seen a significant drop during the decade from 2005 to 2015.
Site Logo
November 10th 2016

ASCO Upgrades Guidelines to Include Palliative Care in Standard Oncology Care

Surabhi Dangi-Garimella, PhD
The American Society of Clinical Oncology’s Ad Hoc Palliative Care Expert Panel has developed specific evidence-based recommendations for access to palliative care services for individuals with advanced cancer and for their family caregivers.
Site Logo
November 9th 2016

How Do Distress Tests Impact Cancer Care Providers?

Surabhi Dangi-Garimella, PhD
A study published in the Journal of the National Comprehensive Cancer Network has found that screening for distress tests improves provider confidence and awareness toward person-centered care.
Site Logo
November 9th 2016

Soda Taxes Pass in Four Cities, But Tobacco Votes Are Mixed

Mary Caffrey
Three of the 4 cities to pass taxes on soda are in Northern California, not far from Berkeley, which passed the nation's first soda tax in 2014.
Site Logo
November 8th 2016

New Digital Tool to Compare Insurance Coverage for Cancer Screening Tests

Surabhi Dangi-Garimella, PhD
The Prevent Cancer Foundation has developed a digital tool that can compare coverage of screening tests for breast, cervical, colorectal, lung, and prostate cancers across health insurance plans available in a specific state.
Site Logo
November 8th 2016

Humana's Roy A. Beveridge, MD, to Give Keynote at Patient-Centered Oncology Care

With value-based reimbursement now far from its infancy, the chief medical officer for Humana will forecast what’s ahead in payment reform-and how oncology connects with what is happening in primary care, hospitals, and the pharmaceutical industry. Roy A. Beveridge, MD, will open Patient-Centered Oncology Care, which will meet November 17-18, 2016, in Baltimore, Maryland.
Site Logo
November 7th 2016

Meta-Analysis Confirms Clinical Advantage of BRAF/MEK and PD-1 Inhibitors in Melanoma

Surabhi Dangi-Garimella, PhD
Based on a retrospective meta-analysis of clinical trial data, authors of a recent paper in JAMA Oncology concluded that BRAF/MEK and programmed death receptor-1 (PD-1) inhibitors were the most effective treatments that were relatively safe in melanoma.
Site Logo
November 7th 2016

Value of Second Opinion in Prostate Cancer Uncertain, Says Hopkins Study

Surabhi Dangi-Garimella, PhD
A new study by researchers at the Johns Hopkins University has found that second opinions did not change treatment choice among men diagnosed with low-risk prostate cancer.
Site Logo
November 4th 2016

A Diagnostic Tool for Cachexia in Cancer Patients Could Save Lives

Surabhi Dangi-Garimella, PhD
Researchers from Canada’s McGill University have developed a potential tool that can detect early signs of cachexia in cancer patients, which could impact survival.
Site Logo
November 4th 2016

Genetic Counseling Prerequisite Reduced Appropriate Testing, Study Finds

Surabhi Dangi-Garimella, PhD
A new study in the Journal of Oncology Practice has found that the health plan requirement of counseling by certified geneticists could have led to patient access issues in oncology.
Site Logo
November 3rd 2016

ASCO's Collaboration Will Expand the Reach of COME HOME for Oncology Patients

Surabhi Dangi-Garimella, PhD
The American Society of Clinical Oncology (ASCO) has announced that it is collaborating with Innovative Oncology Business Solutions, Inc, on ASCO COME HOME.
Segment 8 - Covering the Gaps in Cancer Survivor Care
November 3rd 2016

Segment 8 - Covering the Gaps in Cancer Survivor Care

How can care providers ensure cancer survivors continue to receive adequate follow-up care post treatment?
Segment 7 - Successful Discussions on Advance Care Planning and EOL
November 3rd 2016

Segment 7 - Successful Discussions on Advance Care Planning and EOL

How can discussions on advance care planning and end-of-life care be successfully broached with patients and their family members?
Segment 6 - Reimbursing Value-Based Oncology Care
November 3rd 2016

Segment 6 - Reimbursing Value-Based Oncology Care

Panelists discussed how patient-centered care can be valuated in the changing healthcare climate.
Segment 5 - An Ideal Patient Portal
November 3rd 2016

Segment 5 - An Ideal Patient Portal

Is there anything like an ideal patient portal that can cater to a broad range of patients? According to Rebekkah Schear, MIA, what patient portals lack is a holistic approach toward the patient.
Segment 4 - Overcoming Barriers With Data Exchange
November 3rd 2016

Segment 4 - Overcoming Barriers With Data Exchange

How can we create more standardized health information platforms that can easily exchange patient information?
Segment 3 - Challenges With Oncology Care Navigation
November 3rd 2016

Segment 3 - Challenges With Oncology Care Navigation

Cancer is a complex disease to treat an patients can be overwhelmed by the number of care providers that they have to consult with. In this scenario, care navigators can provide significant support to patients and their family members.
Segment 2 - Documenting the Treatment Plan
November 3rd 2016

Segment 2 - Documenting the Treatment Plan

Panelists discuss the need for documenting a treatment plan early in patient care.
Segment 1 - Patient-Centered Care and Shared Decisions in Oncology
November 3rd 2016

Segment 1 - Patient-Centered Care and Shared Decisions in Oncology

Joseph Alvarnas, MD, editor-in-chief of Evidence-Based-OncologyTM spoke with Rebekkah Schear, MIA, and Michael Kolodziej, MD, to discuss the progress and challenges in oncology care.
Dr Andrew L. Pecora Outlines Issues Oncologists Have With Value Frameworks
November 2nd 2016

Dr Andrew L. Pecora Outlines Issues Oncologists Have With Value Frameworks

Oncologists are aware of the various value frameworks that have popped up recently, but they are still in the first phase and many oncologists have issues with the frameworks, said Andrew L. Pecora, MD, FACP, CPE, chief innovation officer professor and vice president of cancer services at the John Theurer Cancer Center.
Site Logo
November 1st 2016

Chemo Brain May Have a Solution: Insight

Surabhi Dangi-Garimella, PhD
A new study suggests that a Web-based intervention could improve a cancer survivor’s cognitive function post treatment.
<1
...
848586878889909192
...
181>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo